Immunotherapy in small bowel adenocarcinoma: a potential role?

被引:2
作者
Vitiello, Francesco [1 ]
Cereda, Stefano [1 ]
Foti, Silvia [1 ]
Liscia, Nicole [1 ]
Mazza, Elena [1 ]
Ronzoni, Monica [1 ]
Cascinu, Stefano [1 ]
机构
[1] Univ Vita Salute San Raffaele, Dept Med Oncol, Comprehens Canc Ctr, Osped San Raffaele, Milan, Italy
关键词
Small bowel cancer; metastatic cancer; predictive markers; PDL-1; MSI; TMB; duodenal cancer; jejunal cancer; ileum tumor; CANCER;
D O I
10.1080/25785826.2023.2220938
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Small bowel adenocarcinoma (SBA) is a rare tumor with an unfavorable prognosis, and due to its rarity, few studies on its treatment are available. Chemotherapy remains the standard of treatment in advanced disease. Recently immunotherapy has demonstrated to be a valid therapeutic option for many solid tumors. We reviewed the data published in literature to understand the impact of immunotherapy in this cancer.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [31] Small Bowel Adenocarcinoma: Etiology, Presentation, and Molecular Alterations
    Pedersen, Katrina S.
    Raghav, Kanwal
    Overman, Michael J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (09): : 1135 - 1141
  • [32] Bevacizumab in metastatic small-bowel adenocarcinoma: A systematic review and meta-analysis
    Paulo Vergara, John
    Leoncio Sacdalan, Danielle Benedict
    Amurao-Amante, Madelaine
    Lee Sacdalan, Dennis
    RARE TUMORS, 2019, 11
  • [33] Current Status of Immunotherapy in Management of Small Bowel Neuroendocrine Tumors
    Fields, Brittany C.
    Ayabe, Reed I.
    Seo, Y. David
    Maxwell, Jessica E.
    Halperin, Daniel M.
    CURRENT ONCOLOGY REPORTS, 2024, 26 (11) : 1530 - 1542
  • [34] Systemic Treatments for Advanced Small Bowel Adenocarcinoma: A Systematic Review
    Di Nardo, Paola
    Garattini, Silvio Ken
    Torrisi, Elena
    Fanotto, Valentina
    Miolo, Gianmaria
    Buonadonna, Angela
    Puglisi, Fabio
    CANCERS, 2022, 14 (06)
  • [35] Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators
    Moon, Yong Wha
    Rha, Sun Young
    Shin, Sang Joon
    Chang, Hyun
    Shim, Hyo Sup
    Roh, Jae Kyung
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (03) : 387 - 394
  • [36] Adjuvant Chemotherapy for Small Bowel Adenocarcinoma after Curative Surgery
    Koo, Dong Hoe
    Yun, Sung-Cheol
    Hong, Yong Sang
    Ryu, Min-Hee
    Lee, Jae-Lyun
    Chang, Heung-Moon
    Kang, Yoon-Koo
    Kim, Song-Cheol
    Han, Duck-Jong
    Lee, Young-Joo
    Kim, Tae Won
    ONCOLOGY, 2011, 80 (3-4) : 208 - 213
  • [37] Natural history and prognostic factors for localised small bowel adenocarcinoma
    Colina, Andreina
    Hwang, Hyunsoo
    Wang, Huamin
    Katz, Matthew H. G.
    Sun, Ryan
    Lee, Jeffrey E.
    Thomas, Jane
    Tzeng, Ching-Wei
    Wolff, Robert A.
    Raghav, Kanwal
    Overman, Michael J.
    ESMO OPEN, 2020, 5 (06)
  • [38] Small Bowel Adenocarcinoma - Report of Two Cases and Review of Literature
    Umman, Philip
    Adiyodi, Vineeth
    Narayan, Chanchal
    INDIAN JOURNAL OF SURGERY, 2013, 75 (02) : 123 - 127
  • [39] The risk of small bowel adenocarcinoma in patients with Crohn's disease
    Lech, Gustaw
    Korcz, Wojciech
    Kowalczyk, Emilia
    Chaber, Andrzej
    Slodkowski, Maciej
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2020, 15 (04): : 309 - 313
  • [40] Small Bowel Adenocarcinoma: a Nationwide Population-Based Study
    Mohammed, Abdul
    Trujillo, Sophie
    Ghoneim, Sara
    Paranji, Neethi
    Waghray, Nisheet
    JOURNAL OF GASTROINTESTINAL CANCER, 2023, 54 (01) : 67 - 72